240 related articles for article (PubMed ID: 27906679)
21. Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2
Hu Y; Wang S; Ding N; Li N; Huang J; Xiao Z
Clin Breast Cancer; 2020 Aug; 20(4):e403-e409. PubMed ID: 32201163
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of combined preoperative fibrinogen-albumin ratio and platelet-lymphocyte ratio score in patients with breast cancer: A prognostic nomogram study.
Zheng Y; Wu C; Yan H; Chen S
Clin Chim Acta; 2020 Jul; 506():110-121. PubMed ID: 32156604
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer.
Gu X; Gao XS; Cui M; Xie M; Peng C; Bai Y; Guo W; Han L; Gu X; Xiong W
Oncotarget; 2016 Aug; 7(31):49878-49887. PubMed ID: 27409665
[TBL] [Abstract][Full Text] [Related]
24. The Prognostic Value of PLR in Lung Cancer, a Meta-analysis Based on Results from a Large Consecutive Cohort.
Ding N; Pang Z; Shen H; Ni Y; Du J; Liu Q
Sci Rep; 2016 Oct; 6():34823. PubMed ID: 27703265
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
26. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.
Ethier JL; Desautels D; Templeton A; Shah PS; Amir E
Breast Cancer Res; 2017 Jan; 19(1):2. PubMed ID: 28057046
[TBL] [Abstract][Full Text] [Related]
27. Prediction of Sentinel Lymph Node Metastasis Using the Platelet-to-lymphocyte Ratio in T1 Breast Cancer.
Takada K; Kashiwagi S; Asano Y; Goto W; Kouhashi R; Yabumoto A; Morisaki T; Shibutani M; Takashima T; Fujita H; Hirakawa K; Ohira M
Anticancer Res; 2020 Apr; 40(4):2343-2349. PubMed ID: 32234936
[TBL] [Abstract][Full Text] [Related]
28. Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery.
Yu J; Ding Z; Yang Y; Liu S
Medicine (Baltimore); 2018 Jun; 97(25):e11002. PubMed ID: 29923983
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients.
Gu X; Sun S; Gao XS; Xiong W; Qin S; Qi X; Ma M; Li X; Zhou D; Wang W; Yu H
Sci Rep; 2016 Mar; 6():23893. PubMed ID: 27025911
[TBL] [Abstract][Full Text] [Related]
30. [Meta-analysis of Platelet Lymphocyte Ratio as A Prognostic Factor for
Non-small Cell Lung Cancer].
Chen H; Xue H; Liu W; Wu F; Wang Y; Gao H
Zhongguo Fei Ai Za Zhi; 2019 May; 22(5):289-298. PubMed ID: 31109438
[TBL] [Abstract][Full Text] [Related]
31. Platelet-to-lymphocyte ratio as a potential prognostic factor in nasopharyngeal carcinoma: A meta-analysis.
Cen RX; Li YG
Medicine (Baltimore); 2019 Sep; 98(38):e17176. PubMed ID: 31567957
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients.
Li W; Tao L; Lu M; Xiu D
Medicine (Baltimore); 2018 Feb; 97(8):e9616. PubMed ID: 29465553
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis.
Tian C; Song W; Tian X; Sun Y
Eur J Clin Invest; 2018 May; 48(5):e12917. PubMed ID: 29469190
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
Ma W; Zhang P; Qi J; Gu L; Zang M; Yao H; Shi X; Wang C; Jiang Y
Sci Rep; 2016 Oct; 6():35378. PubMed ID: 27739490
[TBL] [Abstract][Full Text] [Related]
35. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
36. Platelet-lymphocyte ratio as a potential prognostic factor in gynecologic cancers: a meta-analysis.
Jiang S; Liu J; Chen X; Zheng X; Ruan J; Ye A; Zhang S; Zhang L; Kuang Z; Liu R
Arch Gynecol Obstet; 2019 Oct; 300(4):829-839. PubMed ID: 31385023
[TBL] [Abstract][Full Text] [Related]
37. Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Cunningham D; Mudan S
Med Oncol; 2014 Oct; 31(10):239. PubMed ID: 25218270
[TBL] [Abstract][Full Text] [Related]
38. The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinoma.
Yuk HD; Kang M; Hwang EC; Park JY; Jeong CW; Song C; Seo SI; Byun SS; Kwak C; Hong SH; Chung J; Lee H;
Investig Clin Urol; 2020 Sep; 61(5):475-481. PubMed ID: 32734724
[TBL] [Abstract][Full Text] [Related]
39. Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis.
Li B; Zhou P; Liu Y; Wei H; Yang X; Chen T; Xiao J
Clin Chim Acta; 2018 Aug; 483():48-56. PubMed ID: 29678631
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
Shao Y; Li W; Wang D; Wu B
World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
